近年来随着控制体内免疫反应的免疫检查点蛋白(如PD1, PD-L1,CTLA4和CEACAM1等)的发现,基于免疫检查点的抗体药物在癌症ZL中作用突出。为满足更多新抗体药物的研发需求,复百澳生物推出热门的免疫检查点稳定细胞系产品,加速免疫疗法中相关抗体药物进入研发及获批的进程。
复百澳公司所有的免疫检查点稳定细胞系产品均可用于筛选结合免疫检查点蛋白的高亲和力抗体。除稳定细胞系外,也可以提供免疫
检查点慢病毒颗粒和
免疫检查点普通质粒等现货产品
。
VTCN1、CTLA4、LAG3、ERBB2、TNFRSF9、CD27、FBCGR2A、TNFRSF4、FLT3、FBCGRT、CD276、CD38、CD47、CD80、HAVCR2、MS4A1、EGFR、TNFSF4、BTLA、FBCGR2B、CD40、CD86、SIRPA、CD52、CD200R1、FBCGR2C、VSIR、CD160、TNFRSF18、TIGIT、PDCD1LG2、CD40LG、PVR、CLEC4G、CD28、CD226、CEACAM1 附.产品列表
货 号 | 基 因 | REFSEQ ID | 细胞系 |
FBC-112 | VTCN1 | NM_024626.3 | CHO |
FBC-113 | CTLA4 | NM_005214 | CHO |
FBC-114 | LAG3 | NM_002286 | CHO |
FBC-115 | ERBB2 | NM_004448 | CHO |
FBC-116 | TNFRSF9 | NM_001561 | CHO |
FBC-121 | CD27 | NM_001242 | CHO |
FBC-122 | FBCGR2A | NM_001136219 | CHO |
FBC-123 | TNFRSF4 | NM_003327 | CHO |
FBC-124 | FLT3 | NM_004119 | CHO |
FBC-125 | FBCGRT | NM_001136019 | CHO |
FBC-126 | CD276 | NM_001024736 | CHO |
FBC-127 | CD38 | NM_001775 | CHO |
FBC-128 | CD47 | NM_001777 | CHO |
FBC-129 | CD80 | NM_005191 | CHO |
FBC-130 | HAVCR2 | NM_005191 | CHO |
FBC-131 | MS4A1 | NM_021950 | CHO |
FBC-132 | EGFR | NM_005228 | CHO |
FBC-133 | TNFSF4 | NM_003326 | CHO |
FBC-134 | BTLA | NM_181780 | CHO |
FBC-135 | FBCGR2B | NM_004001 | CHO |
FBC-136 | CD40 | NM_001250 | CHO |
FBC-137 | CD86 | NM_175862 | CHO |
FBC-138 | SIRPA | NM_080792 | CHO |
FBC-139 | CD52 | NM_001803 | CHO |
FBC-140 | CD200R1 | NM_170780 | CHO |
FBC-141 | FBCGR2C | NM_201563 | CHO |
FBC-142 | VSIR | NM_022153 | CHO |
FBC-143 | CD160 | NM_007053 | CHO |
FBC-144 | TNFRSF18 | NM_004195 | CHO |
FBC-145 | TIGIT | NM_173799 | CHO |
FBC-146 | PDCD1LG2 | NM_025239 | CHO |
FBC-147 | CD40LG | NM_000074 | CHO |
FBC-2084 | PVR | NM_006505.5 | CHO |
FBC-2085 | CLEC4G | NM_198492.3 | CHO |
FBC-2086 | CD28 | NM_006139.4 | CHO |
FBC-2087 | CD226 | NM_001303618.2 | CHO |
FBC-2088 | CEACAM1 | NM_001712.5 | CHO |
资料下载:
反.png
附件下载 (下载 5 次)
正.png
附件下载 (下载 3 次)
请 [登录] 后再下载!